Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sannova, Eisai's pharmaceutical manufacturing and marketing unit, has submitted an application for partial change of Neuzym label to Japan's Ministry of Health, Labour and Welfare (MHLW).
Subscribe to our email newsletter
Neuzym is egg white lysozyme preparation.
The application holds good to Neuzym Series’ all six products, pharmalive.com reported.
The portfolio of products includes Neuzym Tablets (10 mg, 30 mg and 90 mg), Neuzym Granules (10%), Neuzym Fine Granules
(20%), and Neuzym Syrup (0.5%).
The company intends to make changes to the dosage and administration besides removing alveolar pyorrhea and other conditions as approved indications for the product.